Tatsis Ourania 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Tatsis Ourania（CIK 1789815）在 1 家公司共报告 16 笔 SEC Form 4 内部人交易（最近一笔 2026-07-23）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-23 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | 买入 | 8,251 | $0 |
| 2026-07-07 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | 卖出 | 1,500 | $787,485 |
| 2026-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | 卖出 | 1,627 | $789,274 |
| 2026-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | 卖出 | 260 | $126,451 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | 买入 | 5,789 | $0 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | 卖出 | 2,294 | $1.1M |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | 卖出 | 609 | $298,081 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | 卖出 | 368 | $174,314 |
| 2026-02-18 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | 卖出 | 3,804 | $1.9M |
| 2026-02-18 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | 卖出 | 1,500 | $749,985 |
| 2026-02-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | 卖出 | 2,140 | $1.0M |
| 2026-02-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | 卖出 | 466 | $214,560 |
| 2026-01-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | 买入 | 7,866 | $0 |
| 2026-01-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | 买入 | 3,883 | $0 |
| 2026-01-09 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | 卖出 | 4,500 | $2.1M |
| 2025-12-05 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | 卖出 | 4,500 | $2.0M |
来源：SEC Form 4 申报文件 · 截至 2026-07-23